Literature DB >> 26669708

Comparison of classification methods in breath analysis by electronic nose.

Jan Hendrik Leopold1, Lieuwe D J Bos, Peter J Sterk, Marcus J Schultz, Niki Fens, Ildiko Horvath, Andras Bikov, Paolo Montuschi, Corrado Di Natale, Deborah H Yates, Ameen Abu-Hanna.   

Abstract

Currently, many different methods are being used for pre-processing, statistical analysis and validation of data obtained by electronic nose technology from exhaled air. These various methods, however, have never been thoroughly compared. We aimed to empirically evaluate and compare the influence of different dimension reduction, classification and validation methods found in published studies on the diagnostic performance in several datasets. Our objective was to facilitate the selection of appropriate statistical methods and to support reviewers in this research area. We reviewed the literature by searching Pubmed up to the end of 2014 for all human studies using an electronic nose and methodological quality was assessed using the QUADAS-2 tool tailored to our review. Forty-six studies were evaluated regarding the range of different approaches to dimension reduction, classification and validation. From forty-six reviewed articles only seven applied external validation in an independent dataset, mostly with a case-control design. We asked their authors to share the original datasets with us. Four of the seven datasets were available for re-analysis. Published statistical methods for eNose signal analysis found in the literature review were applied to the training set of each dataset. The performance (area under the receiver operating characteristics curve (ROC-AUC)) was calculated for the training cohort (in-set) and after internal validation (leave-one-out cross validation). The methods were also applied to the external validation set to assess the external validity of the performance. Risk of bias was high in most studies due to non-random selection of patients. Internal validation resulted in a decrease in ROC-AUCs compared to in-set performance:  -0.15,-0.14,-0.1,-0.11 in dataset 1 through 4, respectively. External validation resulted in lower ROC-AUC compared to internal validation in dataset 1 (-0.23) and 3 (-0.09). ROC-AUCs did not decrease in dataset 2 (+0.07) and 4 (+0.04). No single combination of dimension reduction and classification methods gave consistent results between internal and external validation sets in this sample of four datasets. This empirical evaluation showed that it is not meaningful to estimate the diagnostic performance on a training set alone, even after internal validation. Therefore, we recommend the inclusion of an external validation set in all future eNose projects in medicine.

Entities:  

Mesh:

Year:  2015        PMID: 26669708     DOI: 10.1088/1752-7155/9/4/046002

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  15 in total

1.  Diagnosis of pulmonary tuberculosis and assessment of treatment response through analyses of volatile compound patterns in exhaled breath samples.

Authors:  Nicola M Zetola; Chawangwa Modongo; Ogopotse Matsiri; Tsaone Tamuhla; Bontle Mbongwe; Keikantse Matlhagela; Enoch Sepako; Alexandro Catini; Giorgio Sirugo; Eugenio Martinelli; Roberto Paolesse; Corrado Di Natale
Journal:  J Infect       Date:  2016-12-22       Impact factor: 6.072

2.  Using a chemiresistor-based alkane sensor to distinguish exhaled breaths of lung cancer patients from subjects with no lung cancer.

Authors:  Jiunn-Liang Tan; Zheng-Xin Yong; Chong-Kin Liam
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

3.  In vitro detection of common rhinosinusitis bacteria by the eNose utilising differential mobility spectrometry.

Authors:  Jussi Virtanen; Lauri Hokkinen; Markus Karjalainen; Anton Kontunen; Risto Vuento; Jura Numminen; Markus Rautiainen; Niku Oksala; Antti Roine; Ilkka Kivekäs
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-24       Impact factor: 2.503

4.  Smelling the Diagnosis: The Electronic Nose as Diagnostic Tool in Inflammatory Arthritis. A Case-Reference Study.

Authors:  Marjolein P Brekelmans; Niki Fens; Paul Brinkman; Lieuwe D Bos; Peter J Sterk; Paul P Tak; Daniëlle M Gerlag
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

5.  BreathDx - molecular analysis of exhaled breath as a diagnostic test for ventilator-associated pneumonia: protocol for a European multicentre observational study.

Authors:  Pouline M P van Oort; Tamara Nijsen; Hans Weda; Hugo Knobel; Paul Dark; Timothy Felton; Nicholas J W Rattray; Oluwasola Lawal; Waqar Ahmed; Craig Portsmouth; Peter J Sterk; Marcus J Schultz; Tetyana Zakharkina; Antonio Artigas; Pedro Povoa; Ignacio Martin-Loeches; Stephen J Fowler; Lieuwe D J Bos
Journal:  BMC Pulm Med       Date:  2017-01-03       Impact factor: 3.317

6.  Screening of Obstructive Sleep Apnea Syndrome by Electronic-Nose Analysis of Volatile Organic Compounds.

Authors:  Simone Scarlata; Giorgio Pennazza; Marco Santonico; Simona Santangelo; Isaura Rossi Bartoli; Chiara Rivera; Chiara Vernile; Antonio De Vincentis; Raffaele Antonelli Incalzi
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

Review 7.  Molecular Engineering of Free-Base Porphyrins as Ligands-The N-H⋅⋅⋅X Binding Motif in Tetrapyrroles.

Authors:  Marc Kielmann; Mathias O Senge
Journal:  Angew Chem Int Ed Engl       Date:  2018-11-05       Impact factor: 15.336

8.  Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study.

Authors:  Kevin Lamote; Paul Brinkman; Lore Vandermeersch; Matthijs Vynck; Peter J Sterk; Herman Van Langenhove; Olivier Thas; Joris Van Cleemput; Kristiaan Nackaerts; Jan P van Meerbeeck
Journal:  Oncotarget       Date:  2017-09-27

9.  Improving lung cancer diagnosis by combining exhaled-breath data and clinical parameters.

Authors:  Sharina Kort; Marjolein Brusse-Keizer; Jan Willem Gerritsen; Hugo Schouwink; Emanuel Citgez; Frans de Jongh; Jan van der Maten; Suzy Samii; Marco van den Bogart; Job van der Palen
Journal:  ERJ Open Res       Date:  2020-03-16

10.  Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank.

Authors:  Ekaterina Krauss; Jana Haberer; Olga Maurer; Guillermo Barreto; Fotios Drakopanagiotakis; Maria Degen; Werner Seeger; Andreas Guenther
Journal:  J Clin Med       Date:  2019-10-16       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.